Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.

UnknownOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

March 24, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Interventions
DRUG

Belantamab mafodotin

At least one dose of belantamab mafodotin as part of the compassionate use or the expanded access program in Spain between November 2019 and June 2021.

Trial Locations (62)

Unknown

RECRUITING

H. Universitario de Albacete, Albacete

RECRUITING

H. Doctor José Molina Orosa, Arrecife

RECRUITING

H. San Agustín, Avilés

RECRUITING

H. Ntra. Señora Sonsoles, Ávila

RECRUITING

H. Clinic de Barcelona, Barcelona

RECRUITING

H. Moises Broggi, Barcelona

RECRUITING

H. Vall d' Hebron, Barcelona

RECRUITING

H. Basurto, Bilbao

RECRUITING

H. Cruces, Bilbao

RECRUITING

H. Calahorra, Calahorra

RECRUITING

H. Reina Sofía, Córdoba

RECRUITING

H. General Elche, Elche

RECRUITING

H. Fuenlabrada, Fuenlabrada

RECRUITING

H. Galdakao, Galdakao

RECRUITING

H. Francisco de Borja, Gandia

RECRUITING

ICO Girona, Girona

RECRUITING

H. Un. Virgen de las Nieves, Granada

RECRUITING

H. Un. Guadalajara, Guadalajara

RECRUITING

H. Juan Ramón Jiménez, Huelva

RECRUITING

H. Universitario de Jaén, Jaén

RECRUITING

H. Un. Doctor Negrín, Las Palmas de Gran Canaria

RECRUITING

H. Severo Ochoa, Leganés

RECRUITING

H. León, León

RECRUITING

H. San Pedro, Logroño

RECRUITING

H. Un. Lucus Augusti, Lugo

RECRUITING

Fundación Jiménez Díaz, Madrid

RECRUITING

H. Gregorio Marañón, Madrid

RECRUITING

H. Moncloa, Madrid

RECRUITING

H. Ruber Juan Bravo, Madrid

RECRUITING

H. Un. Doce de Octubre, Madrid

RECRUITING

H. Un. Infanta Sofía, Madrid

RECRUITING

H. Un. La Paz, Madrid

RECRUITING

H. Un. La Princesa, Madrid

RECRUITING

H. Un. Puerta del Hierro, Madrid

RECRUITING

H. Un. Quirón Salud, Madrid

RECRUITING

H.M. Sanchinarro, Madrid

RECRUITING

Hospital Clínico San Carlos, Madrid

RECRUITING

Hospital Universitario Henares, Madrid

RECRUITING

Hospital Universitario Ramón y Cajal, Madrid

RECRUITING

H. Virgen de la Victoria, Málaga

RECRUITING

H. Rey Juan Carlos, Móstoles

RECRUITING

H. Morales Meseguer, Murcia

RECRUITING

H. Un. Virgen de la Arrixaca, Murcia

RECRUITING

H. Universitario Central Asturias, Oviedo

RECRUITING

H. Son Llatzer, Palma de Mallorca

RECRUITING

H. Un. Son Espases, Palma de Mallorca

RECRUITING

H. Montecelo, Pontevedra

RECRUITING

H. Un. Salamanca, Salamanca

RECRUITING

H. Un. Canarias, Santa Cruz de Tenerife

RECRUITING

H. Un. Marqués de Valdecilla, Santander

RECRUITING

H. General Segovia, Segovia

RECRUITING

H. Un. Virgen de Valme, Seville

RECRUITING

H. Virgen del Rocío, Seville

RECRUITING

H. Mutua Terrasa, Terrassa

RECRUITING

H. Ntra. Señora del Prado, Toledo

RECRUITING

H. Un. Torrejón, Torrejón de Ardoz

RECRUITING

H. Un. Dr. Peset, Valencia

RECRUITING

H. Universitario de la Fe, Valencia

RECRUITING

H. Universitario de Valladolid, Valladolid

RECRUITING

H. Clinico Un. Lozano Blesa, Zaragoza

RECRUITING

H. Miguel Servet, Zaragoza

RECRUITING

H. Royo Villanova, Zaragoza

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

PETHEMA Foundation

OTHER

NCT05297240 - Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain. | Biotech Hunter | Biotech Hunter